Primary Record
Salmeterol
- In stock
- 7,159 g
- Purity
- 98.4 %
- CAS
- 89365-50-4
Compound Identifiers & Properties
- CAS
- 89365-50-4
- PubChem CID
- 5152
- SMILES
- C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
- Canonical SMILES
- OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O
Names & Synonyms
- Salmeterol
- Serevent
- Astmerole
- Aeromax
- Salmeterolum
- 89365-50-4
- salmeterol xinafoate
- Salmeterolum [Latin]
- Salmetedur
- Arial
- Fujimycin
- SALMATEROL
- Seretide
- Neovent
- (s)-salmeterol
- Adoair
- Advair
- Beglan
- Soltel
- Seretide Diskus
- Salmeterol?
- Advair Diskus
- Salmeterol-d3
- Salmeterolxinafoate
- Seretide Accuhaler
- Serevent (R)
- Serevent (TN)
- Fluticasonepropiponate
- SALMETEROLO
- SN408D
- ADVAIR HFA
- Salmeterol (USAN/INN)
- GR 33343X
- RefChem:56523
- SALMETEROL [MI]
- Fluticasone / Salmeterol
- Salmeterol [USAN:BAN:INN]
- AC1L1JPX
- SALMETEROL [INN]
- Prestwick3_000945
- Salmeterol Dimer Impurity
- 2I4BC502BT
- SALMETEROL [HSDB]
- SALMETEROL [USAN]
- Salmeterol EP Impurity D
- Salmeterol EP Impurity G
- UNII-2I4BC502BT
- ACMC-1C1VM
- DTXSID6023571
- SALMETEROL [VANDF]
- Advair Diskus 100/50
- Advair Diskus 250/50
- Advair Diskus 500/50
- D0L5YV
- C25H37NO4
- HSDB 7315
- Salmeterol [USAN:INN:BAN]
- SCHEMBL4767
- DTXCID803571
- GIIZNNXWQWCKIB-UHFFFAOYSA-N
- CHEMBL1263
- SALMETEROL [WHO-DD]
- Lopac0_001100
- BSPBio_000910
- GTPL559
- cc-441
- MLS000759000
- MLS001424322
- Salmeterol Related Compound H
- 2''-O-Rhamnosylicariside II
- Advair HFA Inhalation Aerosol
- GR 33343 X
- 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
- BPBio1_001002
- CHEBI:9011
- orb1309132
- Salmeterol Xinafoate Impurity 1
- GR-33343-X
- phenol chloroform isoamyl alcohol
- Salmeterol-fluticasone propionate mixt.
- SCHEMBL29393289
- BDBM25771
- CHEBI:64064
- CTK4C0163
- CID5152
- MSK1377
- R03AC12
- SalMeterol Xinafoate Adduct IMpurity
- GR-33343X
- MFCD00867037
- GLXC-07244
- HMS2052H13
- HMS2090E17
- HMS2097N12
- HMS3268K19
- HMS3394H13
- HMS3412P13
- HMS3714N12
- HMS3886G10
- HMS5084P12
- AMY37616
- BCP04199
- EX-A4409
- KS-00000L6B
- Tox21_113584
- C25-H37-N-O4
- CS0057
- EBC-27015
- MSK1377-100M
- s5527
- Salmeterol Fluticasone Propionate Mixture
- STK629186
- CPD000466295
- AKOS005561914
- MSK1377-1000M
- ACN-040075
- AN-6615
- C25H37NO4.C25H31F3O5S
- CCG-101194
- CCG-205176
- CS-2815
- DB00938
- FS46783
- NC00444
- NSC-272693
- SDCCGSBI-0633788.P001
- 136112-01-1
- MRF-0000468
- NCGC00015938-03
- NCGC00025247-01
- NCGC00025247-02
- AK173141
- AS-56157
- BC202639
- HY-14302
- K590
- LS-29869
- Salmeterol 100 microg/mL in Acetonitrile
- SAM001247096
- SC-23297
- SC-67460
- SMR000466295
- S 2692
- CAS-89365-50-4
- DB-226688
- Fluticasone propionate mixt. with Salmeterol
- Glaxo Wellcome brand of salmeterol xinafoate
- J707.866H
- Salmeterol Solution in Methanol, 100ug/mL
- 2784B
- AB00513972
- FT-0674508
- FT-0674509
- NS00010340
- Salmeterol Solution in Methanol, 1000ug/mL
- TL80090037
- 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol
- Fluticasone propionate and salmeterol xinafoate
- Fluticasone propionate mixture with Salmeterol
- C07241
- C77008
- D05792
- AB00513972-07
- 365S504
- A843150
- C25-H37-N-O4.C25-H31-F3-O5-S
- EN300-18530979
- L000532
- Q424333
- SR-01000076139
- SR-01000076139-2
- SR-01000076139-6
- (+-)-4-Hydroxy-alpha'-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol
- (+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol
- BRD-A01320529-001-05-9
- BRD-A01320529-104-10-1
- BRD-A01320529-104-11-9
- BRD-A01320529-104-12-7
- 4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol
- 4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol
- Fluticasone propionate mixture with Salmeterol xinafoate
- 1330076-52-2
- 4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol
- 94749-08-3
- 1,3-Benzenedimethanol, 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
- 1,3-Benzenedimethanol, 4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-
- 2-(hydroxymethyl)-4-[1-hydroxy-2-({6-[(4-phenylbutyl)oxy]hexyl}amino)ethyl]phenol
- 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-
- 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl-, (+-)-
- 135271-48-6
- 135293-13-9
- 1391051-88-9
- 2-hydroxymethyl-4-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl}phenol
- (+-)-4-hydroxy-alpha1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-alpha,alpha1-diol
- (RS)-2-(Hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl}phenol
- 1,3-Benzenedimethanol,4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
- 2-(hydroxymethyl)-4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)phenol
- 2-(Hydroxymethyl)-4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]a mino}ethyl]phenol
- 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-phenol
- 4-hydroxy-alpha1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol
- 5-[2-[6-(4-Phenylbutoxy)hexylamino]-1-hydroxyethyl]-2-hydroxybenzenemethanol
- ( inverted question mark) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol; GR 33343X
- (inverted question mark) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol
- 1-hydroxy-2-naphthoic acid;4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-2-methylol-phenol
- 1391052-04-2
- 3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-; 1,3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-, (+/-)-; GR 33343X; Salmeterol; GR 33343X
- 497063-94-2